Thomas K. Rainbolt

Thomas K. Rainbolt

Auto-generated profile, based on publicly available information

Thomas K. Rainbolt

Stanford University

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in Cell Metabolism
Verified
Journal Article
Closed access
TRT. Kelly Rainbolt
T. Kelly Rainbolt
NANeli Atanassova
Neli Atanassova
JGJoseph C. Genereux
Joseph C. Genereux
RWR. Wiseman
R. Wiseman

1 October 2014 in Trends in Endocrinology & Metabolism
Verified
Journal Article
Closed access
TRT. Kelly Rainbolt
T. Kelly Rainbolt
JSJaclyn M. Saunders
Jaclyn M. Saunders
RWR. Wiseman
R. Wiseman

1 March 2016 in Cell Reports
Verified
Journal Article
Open access
TRT. Kelly Rainbolt
T. Kelly Rainbolt
JLJustine Lebeau
Justine Lebeau
CPCristina Puchades
Cristina Puchades
RWR. Wiseman
R. Wiseman
The mitochondrial inner membrane proteases YME1L and OMA1 are critical regulators of essential mitochondrial functions, including inner membrane proteostasis maintenance and mitochondrial dynamics. Here, we show that YME1L and OMA1 are reciprocally degraded in response to distinct types of cellular stress. OMA1 is degraded through a YME1L-dependent mechanism in response to toxic insults that depolarize the mitochondrial membrane. Alternatively, insults that depolarize mitochondria and deplete cellular ATP stabilize active OMA1 and promote YME1L degradation. We show that the differential degradation of YME1L and OMA1 alters their proteolytic processing of the dynamin-like GTPase OPA1, a critical regulator of mitochondrial inner membrane morphology, which influences the recovery of tubular mitochondria following membrane-depolarization-induced fragmentation. Our results reveal the differential stress-induced degradation of YME1L and OMA1 as a mechanism for sensitively adapting mitochondrial inner membrane protease activity and function in response to distinct types of cellular insults.

1 January 2019 in Cell Reports
Verified
Journal Article
Open access
STShuhei Taguwa
Shuhei Taguwa
MYMing Te Yeh
Ming Te Yeh
TRT. Kelly Rainbolt
T. Kelly Rainbolt
ANArabinda Nayak
Arabinda Nayak
HSHao Shao
Hao Shao
JFjudith Frydman
judith Frydman
The spread of mosquito-borne Zika virus (ZIKV), which causes neurological disorders and microcephaly, highlights the need for countermeasures against sudden viral epidemics. Here, we tested the concept that drugs targeting host proteostasis provide effective antivirals. We show that different cytosolic Hsp70 isoforms are recruited to ZIKV-induced compartments and are required for virus replication at pre- and post-entry steps. Drugs targeting Hsp70 significantly reduce replication of different ZIKV strains in human and mosquito cells, including human neural stem cells and a placental trophoblast cell line, at doses without appreciable toxicity to the host cell. By targeting several ZIKV functions, including entry, establishment of active replication complexes, and capsid assembly, Hsp70 inhibitors are refractory to the emergence of drug-resistant virus. Importantly, these drugs protected mouse models from ZIKV infection, reducing viremia, mortality, and disease symptoms. Hsp70 inhibitors are thus attractive candidates for ZIKV therapeutics with the added benefit of a broad spectrum of action.

1 April 2020 in Molecular Cell
Verified
Journal Article
Closed access
WVWillianne I.M. Vonk
Willianne I.M. Vonk
TRT. Kelly Rainbolt
T. Kelly Rainbolt
PDPatrick T. Dolan
Patrick T. Dolan
AWAshley E. Webb
Ashley E. Webb
ABAnne Brunet
Anne Brunet
JFjudith Frydman
judith Frydman

2 September 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
OCOverall Coordination
Overall Coordination
SESuzanne Elsasser
Suzanne Elsasser
LELisa P. Elia
Lisa P. Elia
RMRichard I. Morimoto
Richard I. Morimoto
EPEvan Powers
Evan Powers
JFjudith Frydman
judith Frydman
The condition of having a healthy, functional proteome is known as protein homeostasis, or proteostasis. Establishing and maintaining proteostasis is the province of the proteostasis network, approximately 2,500 genes that regulate protein synthesis, folding, localization, and degradation. The proteostasis network is a fundamental entity in biology with direct relevance to many diseases of protein conformation. However, it is not well defined or annotated, which hinders its functional characterization in health and disease. In this series of manuscripts, we aim to operationally define the human proteostasis network by providing a comprehensive, annotated list of its components. Here, we provide a curated list of 959 unique genes that comprise the protein synthesis machinery, chaperones, folding enzymes, systems for trafficking proteins into and out of organelles, and organelle-specific degradation systems. In subsequent manuscripts, we will delineate the human autophagy-lysosome pathway, the ubiquitin-proteasome system, and the proteostasis networks of model organisms.